Shows
Universe Within PodcastEp. 162 - Dr. Bryan Ardis - Nicotine as Medicine, COVID, & Big PharmaHey everybody! Episode 162 of the show is out. In this episode, I spoke with Dr. Bryan Ardis. Dr. Ardis was recommended to me by a few friends due to his research on the benefits of nicotine. As I work with tobacco as medicine I found his research and ideas to be a great match. I also really respected Dr. Ardis’ stance during COVID, speaking up against tyranny and the lack of science disguised as science. This is a really fascinating conversation about nicotine as medicine which has been much maligned. Nicotine and tobacco are in fact wondrous medicines if us...2025-07-092h 13Universe Within PodcastEp. 162 - Dr. Bryan Ardis - Nicotine as Medicine, COVID, & Big PharmaHey everybody! Episode 162 of the show is out. In this episode, I spoke with Dr. Bryan Ardis. Dr. Ardis was recommended to me by a few friends due to his research on the benefits of nicotine. As I work with tobacco as medicine I found his research and ideas to be a great match. I also really respected Dr. Ardis’ stance during COVID, speaking up against tyranny and the lack of science disguised as science. This is a really fascinating conversation about nicotine as medicine which has been much maligned. Nicotine and tobacco are in fact wondrous medicines if us...2025-07-092h 13
Pharma and BioTech DailyPharma and Biotech Daily: Keeping You Informed on the Latest AdvancementsGood morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.## Breakthrough in Cancer TreatmentExciting news in the world of oncology as a new breakthrough in cancer treatment has been announced. Researchers have discovered a novel therapy that targets specific mutations in cancer cells, leading to significantly improved outcomes for patients. This groundbreaking treatment is set to revolutionize the way we approach cancer care and could potentially save countless lives in the future.## FDA Approval for New DrugIn other news, the FDA has granted approval for a new drug...2025-07-0702 min
The MM+M PodcastKeys for pharma commercialization success. Also ACIP has met, so what now?Pharma commercialization is more of an art than a science.While the focus of an executive is always on the science, the job requires a certain degree of tact. This week, senior pharma editor Lecia Bushak speaks with Justin Holko, SVP of the global oncology/hematology commercial business unit at Regeneron Pharmaceuticals, about the top commercial and marketing trends in pharma.For the second half of the show, the team delves into the paradigm-shifting vaccine advisors meeting. The new look, RFK Jr.-selected ACIP met and recommendations have been made – so what now?2025-07-0236 min
Pharmacy Podcast NetworkNavigating the Next Wave: CEO Insights on Pharma’s Future | Executive DoseIn the premiere episode of The Executive Dose, host Stephen Beckman—CEO of YARAL Pharma—sits down with Nicholas Hart, CEO of IBSA USA, for a timely and insightful conversation on the forces shaping the pharmaceutical industry in 2025. From supply chain disruption and regulatory pressure to innovation in both branded and generic sectors, these two leaders explore how today’s pharma CEOs are steering through uncertainty and preparing for the next wave of transformation.
Key Topics Discussed:
Introduction to The Executive Dose and its mission to spotlight leadership perspectives in pharma.
Stephen Beckman shares his journ...2025-06-2750 minPharma and BioTech DailyPharma and Biotech Daily: Your Essential Dose of Industry NewsGood morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.The CDC's new vaccine advisors are meeting with an unexpected agenda today, including discussions on topics such as Sanofi and Gilead's protein degrader deals, the FDA's review of Sarepta's gene therapy, and a contentious hearing with RFK Jr. over vaccines. The meeting marks the beginning of a new era for the influential vaccine committee. The FDA has named a psychedelic proponent as CDER deputy director, while Nektar has declared a Phase IIb win for eczema treatment. Experts say...2025-06-2602 min
The MM+M PodcastCannes Health 2025: Creativity, culture and the future of pharma, a podcast sponsored by Syneos Health CommunicationsWhat Cannes taught us about health creativity in 2025.Step into the future of health media at the MM+M Media Summit on October
30th, 2025 live in NYC! Join top voices in pharma marketing for a full
day of forward-thinking discussions on AI, streaming, retail media, and
more. Explore the latest in omnichannel strategy, personalization, media
trust, and data privacy—all under one roof. Don’t wait—use promo code
PODCAST for $100 off your individual ticket. Click here to register!
AI Deciphered is back—live in New York City this November 13th.Join
leaders from brands, agencies, and platforms for a future-foc...2025-06-2323 min
Bác sĩ Hoàng Quyết Tiến - ECO PharmaChữa viêm khớp bằng nghệ có hiệu quả không? | ECO Pharma🧡 Nghệ – bí kíp tự nhiên giảm viêm khớp hiệu quảViêm khớp khiến nhiều người phải đối mặt với cơn đau dai dẳng, ảnh hưởng đến sinh hoạt mỗi ngày. Trong tập podcast này, chúng ta sẽ tìm hiểu cách sử dụng nghệ – loại gia vị quen thuộc – để hỗ trợ giảm viêm khớp một cách an toàn và dễ áp dụng.Công thức pha nước nghệHòa 2 thìa cà phê bột nghệ vào 2 cốc nước sôi, thêm mật ong, chanh và một chú...2025-06-1920 min
Bác sĩ Đoàn Vĩnh Bình - ECO PharmaThay van tim có nguy hiểm không? | ECO PharmaThay van tim có nguy hiểm không?Thay van tim là giải pháp quan trọng khi van bị hư hỏng nặng, gây ảnh hưởng đến chức năng tim và cuộc sống người bệnh. Dù là phẫu thuật lớn, nhưng ngày nay nhờ tiến bộ y học, tỷ lệ thành công cao và người bệnh có thể sống khỏe nhiều năm sau mổ.Có mấy loại van tim?Van cơ học: bền chắc, dùng lâu dài nhưng phải uống thuốc chống đ...2025-06-1813 min
Bác sĩ Hoàng Quyết Tiến - ECO PharmaTật khúc xạ ở trẻ em nguy hiểm không? | ECO Pharma👁️🗨️ Tật khúc xạ ở trẻ em – Chỉ cận thị đơn thuần hay ẩn chứa nhiều rủi ro?Rất nhiều phụ huynh nghĩ rằng đeo kính là xong. Nhưng thực tế, tật khúc xạ ở trẻ em – bao gồm cận thị, viễn thị, loạn thị – nếu không được phát hiện và can thiệp kịp thời có thể ảnh hưởng nghiêm trọng đến thị lực vĩnh viễn, kết quả học tập và phát triển trí tuệ của trẻ.👨⚕️ Trong tập podcast này, bác sĩ sẽ phân tích cặn kẽ mức độ nguy hiểm tiềm ẩn củ...2025-06-1318 min
Bác sĩ Hoàng Quyết Tiến - ECO PharmaViêm khớp có ăn được trứng gà không? | ECO PharmaTrứng gà và người bệnh viêm khớpViêm khớp cấp thường khiến khớp sưng đỏ, đau dữ dội. Trong thời gian này, việc ăn trứng gà có thể khiến cơ thể bị “nóng trong”, dễ làm trầm trọng thêm tình trạng viêm. Do đó, nên tạm tránh ăn trứng gà trong giai đoạn cấp tính để giảm kích ứng, hỗ trợ quá trình phục hồi.Khi nào có thể ăn trứng gà lạiSau đợt viêm cấp, sức khỏe cải thiện, người bệnh có th...2025-06-1013 minPharma and BioTech DailyPharma and Biotech Daily: Your Essential Update on the Latest DevelopmentsGood morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.##News 1: FDA approves new drug for treatment of rare genetic diseaseIn a significant development for the rare disease community, the FDA has approved a new drug for the treatment of a rare genetic disease. The drug, which is the first of its kind, has shown promising results in clinical trials and is expected to provide much-needed relief for patients suffering from this condition.##News 2: Biotech company announces breakthrough in cancer researchA leading biotech company has announced a major...2025-06-0902 minPharma and BioTech DailyBiotech Buzz: The Latest in Pharma and Biotech NewsGood morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in the Pharma and Biotech world.Jefferies predicts an increase in small tuck-in deals in the biotech industry as companies face challenges accessing capital. Companies and industry groups are offering solutions to mitigate the impact of Trump tariffs on rare disease, cell, and gene therapy. Pitchbook suggests a shift towards more sustainable investing in biotech VC firms. Gilead is gearing up to challenge J&J in the $20 billion multiple myeloma CAR-T market. PTP's generative AI is revolutionizing data summaries for biotech QC workflows...2025-06-0502 min
Bác sĩ Hoàng Quyết Tiến - ECO PharmaViêm khớp cổ chân có nguy hiểm không? | ECO PharmaViêm khớp cổ chân là tình trạng nghiêm trọng ảnh hưởng đến hơn 350 triệu người toàn cầu. Đây là bệnh lý viêm tổn thương mô mềm xung quanh khớp, gây đau, sưng và cứng khớp.Khớp cổ chân kết nối bàn chân với cẳng chân, bao gồm xương chày, xương mác, xương sên cùng hệ thống sụn, gân, dây chằng. Đặc biệt, lớp sụn khớp cổ chân chỉ dày 1-1,62mm, mỏng hơn nhiều s...2025-06-0107 minPharma and BioTech DailyPharma and Biotech Daily: Navigating Turbulent Times in the Biopharma IndustryGood morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. The biopharma industry is currently facing challenges such as tariff threats and regulatory upheaval. The market has been described as 'moribund' with the need for companies to survive in these tough times. Recent top stories include biotech's struggle with investor pullback due to new tariffs, HHS vaccine requirements sparking controversy, and layoffs in major biopharma companies. AGC Biologics will be at Bio International to showcase their global capabilities in drug production. FDA and NIH are shifting away from...2025-05-2700 min
Bác sĩ Đoàn Vĩnh Bình - ECO PharmaBố bị viêm gan B có lây sang con không? | ECO PharmaBố bị viêm gan B có lây cho con không? Trong số ít trường hợp, người bố dương tính với HBV cũng có thể lây nhiễm bệnh sang con.📌 Viêm gan B lây qua 3 con đường chính:Đường máu: Dùng chung kim tiêm, truyền máu, dụng cụ y tế không vô trùng, dao cạo râu, bàn chải đánh răng dính máu…Đường tình dục: Quan hệ không an toàn với người nhiễm virus.Từ mẹ sang con: Đây là con đường phổ...2025-05-2305 minPharma and BioTech DailySurvival Strategies and Strategic Partnerships: The Latest in Pharma and BiotechGood morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Moderna has withdrawn its application for a combination flu and COVID-19 vaccine after discussions with the FDA. The vaccine had shown efficacy in eliciting antibodies, but the company decided to pull the application. In the biotech market, executives from NextGen companies discussed strategies for surviving in what they described as a "moribund" market during a webinar. Biospace's nextgen companies are thriving in a challenging biotech market. Executives discuss survival strategies in the webinar "Are We There Yet?" Pfizer's $6...2025-05-2201 min
Bác sĩ Đoàn Vĩnh Bình - ECO PharmaTrái cây bổ thận tráng dương | ECO PharmaTrái cây – người bạn đồng hành của sức khỏe nam giớiTrong hành trình chăm sóc sức khỏe sinh lý, việc lựa chọn thực phẩm phù hợp đóng vai trò quan trọng. Trái cây không chỉ là nguồn cung cấp vitamin và khoáng chất mà còn hỗ trợ tăng cường chức năng thận và sinh lý nam giới.Dưới đây là danh sách các loại trái cây có lợi cho sức khỏe nam giới:Lê: Giàu antho...2025-05-2109 minPharma and BioTech DailyPharma and Biotech Daily: Breaking News and Innovations in HealthcareGood morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. ## Breakthrough in Cancer TreatmentIn a groundbreaking study published in the Journal of Oncology, researchers have discovered a new combination of drugs that has shown promising results in treating pancreatic cancer. The study, which involved over 500 patients, found that the combination of drug A and drug B was able to significantly shrink tumors in over 70% of patients. This discovery has the potential to revolutionize the way we treat pancreatic cancer and could lead to improved outcomes for patients in...2025-05-1502 min
Bác sĩ Hoàng Quyết Tiến - ECO PharmaViêm khớp cùng chậu có nguy hiểm không? | ECO PharmaViêm khớp cùng chậu là tình trạng viêm xảy ra tại khớp nối giữa xương cùng và xương chậu, thường gây đau ở vùng lưng dưới, mông và có thể lan xuống chân. Cơn đau thường tăng lên khi đứng lâu, ngồi nhiều hoặc leo cầu thang. Nếu không được phát hiện và điều trị kịp thời, bệnh có thể dẫn đến nhiều biến chứng nghiêm trọng.Những biến chứng tiềm ẩn của viêm khớp cùn...2025-05-1306 min
Healthcare NOW Radio Podcast Network - Discussions on healthcare including technology, innovation, policy, data security, telehealth and more. Visit HealthcareNOWRadio.comFINN Voices: Closing the Pharma-Startup Divide to Accelerate Digital Health with Naomi Fried, PhDClosing the Pharma-Startup Divide to Accelerate Digital Health
On this episode, host Ellie Hanson sits down with Naomi Fried, PhD, founder and CEO of PharmStars, a unique pharma-focused accelerator for digital health startups. Since its founding three years ago, the program has ""graduated"" 79 startups across 7 cohorts. The first three cohort startups have closed more than 98 pharma deals. With her extensive background in healthcare innovation, Naomi shares valuable insights into how startups can navigate pharma partnerships and engage pharma as customers to drive digital health adoption. She offers practical advice for startup founders seeking investment and unveils details of PharmStars’ latest co...2025-01-2522 min
Insights by Pharma.AeroTackling Data, Physical, and Cybersecurity in Pharma ShippingIn this Pharma.Aero podcast episode, industry experts discuss tackling data, physical, and cybersecurity in pharma shipping. Join Frank Van Gelder and his guestsTanguy Bullier, Health Safety Security Environment Director for EMEA at WFSNicola Caristo, Senior Quality Manager at SkyCell, also project expert - Pharma.Aero Security Standards Projectto learn more about the rising need for cybersecurity and the current gaps in digital maturity across the cargo chain. The conversation highlights the need for standardized, global security protocols, with new tools like digital twins and AI seen as p...2024-10-3119 min
Voices of PharmaThe Future of Digital Transformation in the Pharma Industry, ft. Mr. Manish | #E25-Voices of Pharma | Pharma NowIn this episode of the Pharma Now podcast, we speak with Mr. Manish Manakchand, the Commercial Director for IDBS Asia. Mr. Manakchand discusses the company's role in digital transformation within the pharmaceutical industry.
Mr. Manakchand expresses his optimism for the growth of the pharmaceutical industry in Asia, particularly India, driven by factors like talent availability, cost advantages, and the increasing focus on biosimilars. He envisions a significant role for digital transformation in supporting this growth.
Follow our website for in-depth articles and industry updates: https://www.pharmanow.live/
Follow our social media handles:
Facebook: https://www.facebook.com...2024-10-2312 min
Voices of PharmaThe Future of Formulation Science: A Conversation with Dr. Vaibhav Dubey | #E24-Voices of Pharma | Pharma NowIn this episode of the Pharma Now podcast, we speak with Dr. Vaibhav Dubey, General Manager at Kashiv Biosciences. Dr. Dubey shares his inspiring journey in the pharmaceutical industry, from his early days as a student to his current role as a leader in formulation development. He discusses the challenges he has faced in his career and how he has overcome them, as well as his vision for the future of formulation science.
Dr. Dubey also talks about the importance of innovation in the pharmaceutical industry and how his team at Kashu Biosciences is developing cutting-edge formulations...2024-10-1618 min
The MM+M PodcastWhy pharma branded work didn’t make the Cannes cutCollette Douaihy, 2024 Cannes Lions Pharma jury president, CCO at Dentsu Health and 2024 MM+M Health Influencer, explains the dearth of award-caliber, regulated pharma work from this year’s festival in the south of France. Plus, Marc Iskowitz, Lecia Bushak and Jack O’Brien review recent Supreme Court decisions impacting healthcare. These include the court’s biggest abortion-related rulings since overturning Roe v. Wade two years ago to its rejection of the Purdue Pharma nationwide opioid settlement to its rollback of the 40-year-old Chevron defense.
Step into the future of health media at the MM+M Media...2024-07-0343 min
The MM+M PodcastThe expected evolution of pharma interactions: Live from physicians, a podcast sponsored by ImpiricusHCP engagement is constantly evolving and brands are continually adapting. One thing stays the same — trying to connect healthcare professionals to the resources that give their patients the best access to care. Join us and two physicians as they explore the expected evolution of pharma interactions. We will hear from the valuable voice of the physician about the most pressing questions on pharma interaction. What do physicians see as a disconnect with the current pharma engagement model and how they operate on a daily basis? What is missing today in a physician's practice that pharma could deliver or solve fo...2024-06-1428 min
Insights by Pharma.AeroCharting Pharma Logistics Sustainability (2)Pharma.Aero’s collaborative podcast explores the complexity of the life sciences and med tech supply chain, with the valuable contribution of Pharma.Aero global community of members and partners, representing the end-to-end healthcare supply chain. Episode 2 Guests:- Jacques Le Comte, Business Development Manager - Topa Thermal- Samuel Speltdoorn, Business & Network Development Manager Cargo - Brussels Airport- Miro Skorepa, COO and Co-founder - Hive ZoxInterviewed by Alice IacobescuIntroduction by Frank Van Gelder, Secretary General of Pharma.aero The podcast series on...2023-08-0911 min
The MM+M PodcastAgency 100 Studio Session: Marketing attribution comes of age in pharma, a podcast presented by AbelsonTaylorRebecca Visconti has spent her career using data science to help brands figure out which promotional tools are paying their way and which aren't. Now she's taken her talents to healthcare and pharma, a space not previously noted for sophistication in marketing attribution. Rebecca takes us through how her agency, AbelsonTaylor, is helping pharma brands track and measure the impact of each touchpoint with their healthcare practitioner audiences, and the surprises those brands have encountered along the way.Step into the future of health media at the MM+M Media Summit on October
30th, 2025 live in NYC! Join top voices...2023-06-2216 min
The MM+M PodcastGoodRx Health is the one-stop shop for patients — and pharma, a podcast presented by GoodRxStep into the future of health media at the MM+M Media Summit on October
30th, 2025 live in NYC! Join top voices in pharma marketing for a full
day of forward-thinking discussions on AI, streaming, retail media, and
more. Explore the latest in omnichannel strategy, personalization, media
trust, and data privacy—all under one roof. Don’t wait—use promo code
PODCAST for $100 off your individual ticket. Click here to register!
AI Deciphered is back—live in New York City this November 13th.Join
leaders from brands, agencies, and platforms for a future-focused
conversation on how AI is transforming media, marketing...2023-06-1517 min
Off Script: A Pharma Manufacturing Podcast[Solutions Spotlight] Stop the stall: The time is now for predictive maintenance in pharmaPredictive maintenance can help pharma companies can capture enormous value. Digital solutions can help eliminate downtime, reduce maintenance costs and maximize productivity, ultimately unlocking the capacity that is necessary to get the highest quality product to patients who need them most. Senior editor Andrea Corona discusses this with Zach Gilulah, pharma machine health lead at Augury
Read the transcript: https://www.pharmamanufacturing.com/podcasts/off-script-a-pharma-manufacturing-podcast/stop-the-stall-the-time-is-now-for-predictive-maintenance-in-pharma
2022-05-2412 min
The Pharma Marketing PodcastPharma & Modular Content: A Deeper DiveTune in to this episode of the Pharma Marketing Podcast for a deeper dive into pharma and modular content, with Ryan Rosenberg, Director Omnichannel Capabilities @ Sanofi, who shared his insights on making modular content work and why pharma is the perfect candidate for it.2022-04-1226 minThe Pharma Marketing PodcastLet’s talk TALK and Pharma marketingTune in to this episode of the Pharma Marketing Podcast to hear a discussion with Charles Benaiah, Innovator, Founder and CEO of Watzan, Founder of ililli, and Jennifer Ginest, Digital Marketing Manager of PMN on audio and the possibilities of integrating it into your marketing strategy.2022-03-0221 min
The MM+M PodcastThe value of omnichannel marketing for pharma, a podcast presented by HayloMM+M’s GM Steve Madden sat down with Louis Naimoli, director of programmatic for Haylo, a subsidiary of Haymarket Medical Network, for a sponsored podcast discussion on omnichannel marketing, its prevalence in the pharma industry and how Haylo is using the medium to help its clients achieve optimal results and success within their target audiences. Step into the future of health media at the MM+M Media Summit on October
30th, 2025 live in NYC! Join top voices in pharma marketing for a full
day of forward-thinking discussions on AI, streaming, retail media, and
more. Explore the latest in omnichannel st...2022-01-1922 min
The Scope of Practice PodcastNew Year, New Career? Physician opportunities in Pharma & Biotech - Dr. Nerissa KreherEpisode 92 - Is it time for a change? Considering your next career in pharma? Today’s guest is Dr. Nerissa Kreher. Dr. Kreher is the Chief Medical Officer of a biotech company and a pediatric endocrinologist. She transitioned into the biotech/pharma industry early in her career and brings 15 years of experience working in biotech/pharma. Her career in pharma/biotech started in Medical Affairs as a Medical Director. She then strategically moved to another company to gain Clinical Development experience and expertise. She has worked in small to large biotech/pharma organizations including both private and public companies. She...2022-01-0341 min
The MM+M PodcastCTV Advertising: An untapped opportunity for pharma marketers, a podcast presented by PulsePointEvery year, pharma companies spend billions of dollars in the U.S. on TV advertising. But the industry’s media planning and buying are still based largely on assumptions grounded in traditional linear TV—even though TV consumption has become increasingly fragmented across platforms and devices. Today, ads served on internet-connected devices—also known as CTV advertising—present an untapped opportunity for pharma marketers. To take advantage of these, pharma must rethink its media strategy and gain an understanding of the role CTV can play in connecting with audiences across devices and formats.To uncover some key insights...2021-11-0424 min
PODCAST MENSCHBate-papo com João Marinho - CEO Divina Pharma (#03 Podcast Mensch Negócios)Bate-papo com João Marinho (www.instagram.com/joao_marinho_) CEO da Divina Pharma e Sundown Vitaminas (www.sundownvitaminas.com.br) nosso episódio #03. Siga-nos no Instagram (www.instagram.com/revmensch). Apresentação: Rodrigo BossHard (www.instagram.com/rodrigobosshard). Fique Ligado! Acione as notificações, toda semana um conteúdo relevante sobre Empreendedorismo.2021-05-1350 min
Digital PharmaResiliencia, trabajo y aventura en el mundo Pharma, con Ivan Lillo¡Bienvenidos al segundo episodio de la tercera temporada de Digital Pharma!
Comenzado de nuevo con esta serie de la mano de Iván Lillo, Field Force Execution Manager en Novartis Deutschland GmbH. El mundo Pharma está lleno de caminos y de posibilidades, aprovechalas y crea tu camino. Eso es lo que ha hecho nuestro invitado Iván Lillo y le ha llevado hasta Alemania. ¿Cuál es el tuyo?
Esperamos que os inspire y motive escuchar Digital Pharma, nosotros estamos encantados de seguir en este proyecto!
No olvidéis seguirnos para no perd...2021-05-1119 minDigital PharmaUn viaje por el mundo Pharma, con Guillermo Castillo¡Bienvenidos al primer episodio de la tercera temporada de Digital Pharma!
Comenzado de nuevo con esta serie de la mano de Guillermo Castillo, Vice President Head of Market Access International Operations & Excellence en Ipsen. El mundo Pharma está lleno de caminos y de posibilidades y quien mejor que alguien que ha pasado practicamente por todos ellos para contárnoslo. Desde posiciones regionales hasta internacionales la experiencia de Guillermo llega a todos los rincones, simplemente impresionante.
Esperamos que os inspire y motive escuchar Digital Pharma, nosotros estamos encantados de seguir en este proyecto!
No...2021-04-2722 minDigital PharmaConexión Pharma - Gran consumo, con Oliver Pou¡Bienvenidos al quinto episodio de la segunda temporada de Digital Pharma!
En este nuevo episodio contamos con un gran profesional con una experiencia muy extensa, Oliver Pou, Head of Market and Customer Knowledge at Sanofi CHC Iberia. Gracias al haber pasado por varios sectores Oliver por nos dará una visión muy completa sobre el sector y la importancia del departamento en el día a día.
Esperamos que os inspire y motive escuchar Digital Pharma, nosotros estamos encantados de seguir en este proyecto!
No olvidéis seguirnos para no perderos ningún episo...2021-03-0920 min
Datamonitor Healthcare Analyst Podcast2020 Post - ESMO PodcastZach McLellan, Tara Hansen, Tom Tyler, and David Dahan discuss notable presentations and data releases from the 2020 ESMO meeting.
Topics covered in this episode include:
• LEAP-005: Lenvima + Keytruda in solid tumors (1:25)
• Phase III IPATential150 data: ipatasertib in mCRPC (5:59)
• Phase III - JAVELIN HEAD AND NECK 100: Bavencio (12:12)
• Phase III - IMpassion131 and IMpassion130: Tecentriq in TNBC (17:40)
• Phase III - CheckMate 649: Opdivo in gastric cancer + oesophageal cancer (22:52)
• Phase III - CROWN trial: Lorbrena vs. Xalkori in NSCLC (30:20)
To learn more about Datamonitor Healthcare, Biomedtracker, and other offerings from Informa Pharma Intelligence, visit:
pharmaintelligence.informa.com/2020-10-0935 minDatamonitor Healthcare Analyst Podcast2020 Post-ASCO PodcastZach McLellan, Tara Hansen, Tom Tyler, and David Dahan discuss notable presentations and data releases from the 2020 ASCO meeting.
Topics covered in this episode include:
• TIGIT + PD-L1: Tiragolumab w/ Tecentriq for NSCLC (:45)
• Phase III ADAURA trial update: adjuvant Tagrisso for NSCLC (5:10)
• JAVELIN Bladder 100 - Bavencio as maintenance therapy in urothelial carcinoma (10:00)
• Final OS data from TIVO-3 unlikely to lead to US approval for Tivopath in RCC (14:27)
• Phase II Pevonedistat-2001 trial: Pevonedistat for AML/MDS(19:05)
• Phase I/II EVOLVE study: orva-cel for mutliple myeloma (25:05)
• CodeBreak 100 - AMG510 update (32:54)
• ADP-A2M4 SPEAR T cells in solid tumors (38:45)
To learn more about Datamonitor Healthcare, Biom...2020-06-2543 min
Datamonitor Healthcare Analyst Podcast03/13/2020 2019 Earnings PodcastDerek Burkhard and Mike Ramirez discuss notable big pharma full-year 2019 presentations.
Topics covered in this episode include:
• Overall company performance of Merck, Roche, AstraZeneca, Gilead, Sanofi, and GlaxoSmithKline (1:00)
• Current spin-offs & rationale (20:49)
• Discussion on notable big pharma M&A deals, and companies that may be looking to engage in M&A in the near future (27:49)
• China revenues, growth, and the potential impact of COVID-19 (36:42)
To learn more about Datamonitor Healthcare, Biomedtracker, and other offerings from Informa Pharma Intelligence, visit:
pharmaintelligence.informa.com/2020-03-1346 min
Datamonitor Healthcare Analyst Podcast01/30/2020 Post-JPM 2020 PodcastJessica Merrill, Andrew McConaghie, and Mike Ramirez discuss key takeaways from the 2020 J.P. Morgan Healthcare Conference (JPM).
Topics covered in this episode include:
• Intro/general discussion of the meeting (0:00-4:17)
• Focus on execution at this year’s meeting (4:17-6:14)
• Companies that may be poised to make M&A deals in the near future (6:14-9:05)
• Potential reasons behind lack of M&A, including uncertainty around the U.S. election, valuation expectations (9:05-16:49)
• Discussion on drug pricing regulation (16:49-23:31)
• Sessions of particular interest (23:31-34:24)
To learn more about Scrip, Pink Sheet, Datamonitor Healthcare and other offerings from Informa Pharma Intelligence, visit:
pharmaintellig...2020-01-3034 minThe Pharma Marketing PodcastMark Stinson & Bob Baurys of 83bar - Patient ActivationIn this episode of the Pharma Marketing Podcast, we sit down with Mark Stinson and Bob Baurys from 83bar, the #1 patient activation company in the healthcare industry. Mark and Bob bring two unique and highly relevant perspectives to the table from their extensive individual experience in healthcare and pharma marketing (Mark) and provider services (Bob). Bob and Mark have coupled their skills and expertise to create a four-point process and model to effectively educate and inform patients across therapeutic categories and motivate them to see their doctors or participate in clinical trials, detailed in their book, Patient...2019-12-0633 min
Datamonitor Healthcare Analyst Podcast12/03/2019 Pre-ASH PodcastMandy Jackson, David Dahan, Tara Hansen, and Mike Ramirez preview abstracts of interest related to the American Society of Hematology (ASH) annual 2019 meeting.
Topics covered in this episode include:
• Mandy Jackson: Discussion of key presentations in the CAR-T space (1:35)
• David Dahan: Results from late-breaking abstract 3 (LBA3) on CC-486 in acute myeloid leukemia, review of LBA6 on a triple combination of Darzalex, Kyprolis and dexamethasone in multiple myeloma (8:02)
• Tara Hansen: Examination of sutimlimab for cold agglutinin disease (LBA2), as well as Blincyto in B-cell acute lymphoblastic leukemia (LBA1) (17:52)
• Mike Ramirez: Updated results for BELLINI trial in t(11;14) multiple myeloma patients, discussion on LBA5...2019-12-0340 min
Datamonitor Healthcare Analyst Podcast11/01/2019 Aducanumab, Cell and Gene Therapy PodcastPammy Spicer, Amanda Micklus, and Mike Ramirez discuss current events in the healthcare space in the Informa Pharma Intelligence Podcast.
Topics covered in this episode include:
• Pammy Spicer: Biogen's stunning resurrection of aducanumab moves the anti-amyloid antibody from futility to FDA filing for Alzheimer’s (0:47)
• Amanda Micklus: Quick news round of a select key items in the cell and gene therapy sector, including Zolgensma’s and Yescarta’s Q3 sales and Zalmoxis’s withdrawal from the market (18:58)
To learn more about Datamonitor Healthcare, BioMedTracker, and other offerings from Informa Pharma Intelligence, visit:
pharmaintelligence.informa.com/2019-11-0139 min
Datamonitor Healthcare Analyst Podcast10/04/2019 Post-ESMO podcastMike Ramirez, Zach McLellan, David Dahan, and Tara Hansen discuss takeaways related to the European Society for Medical Oncology annual 2019 meeting.
Topics covered in this episode include:
• Mike Ramirez: Discussion of results for AMG 510 in colorectal cancer, as well as updates in first-line non-small cell lung cancer for Tecentriq, Opdivo, and Tagrisso (1:17)
• Zach McLellan: PARP inhibitors dual in ovarian cancer, including updates on Zejula, Lynparza, and veliparib (17:41)
• David Dahan: Phase II results for Debio 1143 combined with chemo-radiotherapy for patients with head and neck cancer and for tucatinib combined with Herceptin for patients with HER2+ colorectal cancer (27:47)
• Tara Hansen: Overview on Keytruda...2019-10-0448 min
Datamonitor Healthcare Analyst Podcast08/30/19 TMB and NASH podcastHannah Cohen and Mike Ramirez discuss current events in the healthcare space in the Informa Pharma Intelligence Podcast.
Topics covered in this episode include:
• Mike Ramirez: Discussion around the Tumor Mutational Burden (TMB) biomarker and results from AstraZeneca’s NEPTUNE trial and Bristol-Myers Squibb’s CheckMate-227 trial (0:53)
• Hannah Cohen: Insights into Intercept’s Ocaliva as the first potential disease-specific therapy for the treatment of NASH and pricing strategies between payers and manufacturers (15:49)
To learn more about Datamonitor Healthcare, BioMedTracker, and other offerings from Informa Pharma Intelligence, visit:
pharmaintelligence.informa.com/2019-08-3036 min
Datamonitor Healthcare Analyst Podcast07/26/2019 Trump Pharma Pricing Policy PodcastLouisa Joseph, Astrid Kurniawan, and Mike Ramirez discuss various proposals related to drug pricing under the Trump administration.
Topics covered in this episode include:
• Louisa Joseph: Discussion around the withdrawal of the Medicare Part D rebate proposal, and the recent Senate Finance Committee’s bill for lowering prescription drug costs (1:17)
• Astrid Kurniawan: International Pricing Index of Medicare Part B drugs and its market implications (13:39)
To learn more about Datamonitor Healthcare, BioMedTracker, and other offerings from Informa Pharma Intelligence, visit:
pharmaintelligence.informa.com/2019-07-2631 minDatamonitor Healthcare Analyst Podcast06/28/2019 Post-ASCO PodcastHardik Patel, Zach McLellan, and Mike Ramirez discuss takeaways related to the American Society for Clinical Oncology annual 2019 meeting.
Topics covered in this episode include:
• Mike Ramirez: Discussion of the ASCO 2019 presentation centered on the potential of STK11/KEAP1 mutations as a predictive biomarker for checkpoint inhibitors in NSCLC (0:57)
• Hardik Patel: Overview of several failed confirmatory trials for PD-1/PD-L1 inhibitors, including KEYNOTE-062, KEYNOTE-240, CheckMate 459, and EAGLE (12:00)
• Mike Ramirez: Refocus on targeted therapies in NSCLC at ASCO 2019, highlighting AMG 510, capmatinib, tepotinib, BLU-667, and TAK-788 results (23:37)
• Zach McLellan: Spotlight on the use of real-world evidence in ASCO 2019 presentations (38:46)
To learn more about Da...2019-06-2849 min
Datamonitor Healthcare Analyst Podcast05/24/2019 Pre-ASCO podcastDavid Dahan, Zach McLellan, and Mike Ramirez preview notable presentations related to the upcoming American Society for Clinical Oncology annual 2019 meeting.
Topics covered in this episode include:
David Dahan
• AstraZeneca’s late breaking abstract will present the first numerical results for POLO, a Phase III trial evaluating Lynparza as single-agent maintenance therapy for frontline, BRCA mutant pancreatic cancer after platinum chemotherapy. In February 2019 AstraZeneca announced that POLO met its primary endpoint of improvement in progression-free survival. Here, we discuss the landscape for PARP inhibitors for pancreatic cancer and what’s next for Lynparza. (1:26)
• Forty Seven will present early data from a Phase...2019-05-2443 min
Datamonitor Healthcare Analyst Podcast05/17/2019 Post-AAN PodcastDominique Fontanilla, Laurie Withington, Stephanie Yip, Pammy Spicer, and Mike Ramirez discuss current events in the healthcare space in the Informa Pharma Intelligence Podcast.
Topics covered in this episode include:
- Clinical trial data from AAN are highlighted for Biogen’s Spinraza, Novartis’ gene therapy Zolgensma, and Roche’s risdiplam in spinal muscular atrophy. In addition, discussion points included in this segment are the potential market competition between the three drugs, differentiating factors, and possible barriers to uptake. (1:46)
- Data presented on a new class of oral CGRP receptor antagonists by Allergan with ubrogepant and atogepant, in acute and episodic migrai...2019-05-171h 02
Datamonitor Healthcare Analyst PodcastMedTech Insight Awards: Why enter podcast?Find out how to write an entry for the MedTech Insight Awards.2019-05-1506 min
Datamonitor Healthcare Analyst Podcast04/19/2019Pammy Spicer, Molly Nelson, Joe Haas, and Mike Ramirez discuss current events in the healthcare space in the Informa Pharma Intelligence Podcast.
Topics covered in this episode include:
- Failure of aducanumab: Pammy Spicer discusses the high-profile failure of aducanumab, as well as the impact on the amyloid hypothesis, the mainstream concept underlying Alzheimer’s disease for over 20 years (1:39)
- Preview of Meddevicetracker report on device regulatory timing: Molly Nelson shares insights from an upcoming report dissecting time to approval for medical devices through different approval pathways and therapeutic areas (19:51)
- Recent results for Ocaliva (OCA) in non-alcoholic steatohepatitis (NASH): Jo...2019-04-1950 minThe Pharma Marketing PodcastThe Pharma Marketing Podcast - An Interview with John Mack (Part 2), hosted by R.J. Lewis and Don LangsdorfIn the second part of our interview John Mack turns the interview around on hosts R.J. Lewis and Don Langsdorf, to find out more on their vision for the Pharma Marketing Network moving forward. R.J. and Don discuss the new mission of the PMN, and its focus on a more collaborative approach with the industry to gain insights and perspectives directly from thought leaders, influencers and experts.2019-04-1722 minThe Pharma Marketing PodcastThe Pharma Marketing Podcast - An Interview with John Mack, hosted by R.J. Lewis and Don LangsdorfR.J. Lewis, Founder and CEO and Don Langsdorf, Director of Digital Solutions & Strategy at eHealthcare Solutions interview John Mack, a.k.a. Pharmaguy, the founder of the Pharma Marketing Network. John shares some of his favorite moments from his 20 years as a highly visible and respected maverick in the pharmaceutical and healthcare marketing world. eHealthcare Solutions took over the Pharma Marketing Network from John in 2018, following his retirement, and relaunched pharma-mkting.com in March of 2019.2019-04-1045 min
Datamonitor Healthcare Analyst Podcast03/19/2019Mandy Jackson, Mike Ramirez, and Stephanie Yip discuss current events in the healthcare space in the Informa Pharma Intelligence Podcast.
Topics covered in this episode include:
- Bristol-Myers Squibb and Celgene merger: overview and latest developments of one of the largest pharma deals ever, as well as the pushback from institutional investors (1:37)
- Selinexor PDUFA for multiple myeloma delayed: discussion of selinexor’s registrational filing for a highly refractory population of hematological cancer patients (16:18)
- Approval of Spravato: analysis of the approval of a nasal spray formulation of esketamine for treatment resistant depression (28:47)
To learn more about Datamonitor Healthcare, Scrip, Pi...2019-03-1945 minDatamonitor Healthcare Analyst PodcastPost ASH PodcastZach McLellan, David Dahan, and Mike Ramirez discuss data from the ASH conference in this Datamonitor Healthcare Analyst Podcast.
Topics covered include:
- New approvals for AML (Daurismo, Venclexta, Xospata) – 0:30
- ASH results from BCMA-directed therapies – 12:25
- JCAR017 and CTL119 in CLL – 25:05
To learn more about Datamonitor Healthcare and our offerings, visit:
pharmaintelligence.informa.com/products-…ealthcare2018-12-1838 minDatamonitor Healthcare Analyst Podcast11.16.18Zach McLellan and Mike Ramirez discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast. Topics covered include:
- Tecentriq Priority Review in TNBC $RHHBY – 0:35
- NKTR-214 & Opdivo data in melanoma $NKTR $BMY – 9:40
- SynthorX IPO – 23:25
To learn more about Datamonitor Healthcare and our offerings, visit:
pharmaintelligence.informa.com/products-…ealthcare2018-11-1635 minDatamonitor Healthcare Analyst Podcast10/26/18Zach McLellan and Astrid Kurniawan discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast.
Topics covered include:
- Lynparza's strong maintenance data from SOLO-1 $AZN $TSRO $CLVS – 0:50
- PI3K inhibitor alpelisib surprises with positive SOLAR-1 data $NVS – 7:54
- Update on the Trump administration's plans to reduce drug costs – 15:22
To learn more about Datamonitor Healthcare and our offerings, visit:
pharmaintelligence.informa.com/products-…ealthcare2018-10-2632 min